logo
Search orAI Icon𝛼SK
ENTITY

Alpine Immune Sciences (ALPN US)

1
Analysis
Health Care • United States
Alpine Immune Sciences, Inc. (AIS) focuses on developing novel protein-based cancer immunotherapies using its proprietary variant ig domain (vIgD) platform technology. The Company develops TIP technology, based on the vIgD platform, to enhance engineered cellular therapies. AIS offers a platform to interact with multiple targets, including many present in the immune synapse.
more
Company Event • 12 Nov 2024 20:00 • Upcoming
Add To Calendar

Q3 2024

Company Event • 01 Aug 2024 06:00 • Upcoming
Add To Calendar

Q2 2024

Company Event • 10 May 2024 04:00 • Upcoming
Add To Calendar

Q1 2024

Company Event • 16 Apr 2024 04:45 • Upcoming
Add To Calendar

Investor Update

Company Event • 11 Apr 2024 05:15 • Latest

Study Update

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x